Reuters logo
BRIEF-Claris Lifesciences approves sale of shares of Otsuka Pharmaceutical India for $20 mln
May 8, 2017 / 8:51 AM / 5 months ago

BRIEF-Claris Lifesciences approves sale of shares of Otsuka Pharmaceutical India for $20 mln

May 8 (Reuters) - Claris Lifesciences Ltd

* Says approved sale of shares of Otsuka Pharmaceutical India to Otsuka Pharmaceutical Factory for $20 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below